News
Novo Nordisk stock rises, Wegovy approved to treat liver disease
Shares of Novo Nordisk (NVO) are rising early Monday after the US Food and Drug Administration approved Wegovy to treat metabolic-associated steatohepatitis (MASH), a serious liver disease. Yahoo Finance Senior Health Reporter Anjalee Khemlani discusses the details.
MASLD has become the most common chronic liver disease worldwide. The authors review the features of the disease as well as ...
The Independent on MSN9d
The silent symptoms of liver disease – and ways to prevent it
One of the challenges with liver disease is that it can be a silent threat. In its early stages, it may cause only vague ...
Using a novel 3D culture system, an international team of researchers have created the first vascularized liver organoid.
The liver develops fat deposits from fructose consumption which results in nonalcoholic fatty liver disease (NAFLD).
Acetaminophen is one of the most common painkillers and is found in hundreds of different medications. While safe at ...
Serious liver disease is becoming more common among Americans who drink heavily, according to a new study from Keck Medicine of USC.
Learn how to stop the progression of fatty liver disease with these common habit changes related to diet, exercise, and ...
Serious infections significantly increase the mortality risk among adults with chronic liver disease, including those without cirrhosis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback